Accelerating botanical drug development and phytopharmaceutical manufacturing through standardized end-to-end analytical and testing platforms.
The pharmaceutical, nutraceutical, and dermocosmetic sectors are undergoing an architectural transition from crude plant extracts to single-molecule active identification and fingerprint-validated formulations.
Secondary metabolites fluctuate wildly due to edaphic and altitudinal factors. Global enterprises can no longer rely on unstandardized supply chains. Our multi-origin analytical screening guarantees consistent compound stoichiometry across seasonal cycles, neutralizing batch-to-batch therapeutic drift.
International pharmaceutical standards (USP, Ph. Eur., CP) require strict elimination of heavy metals, polycyclic aromatic hydrocarbons (PAHs), and over 500 pesticide residues. We enforce supercritical CO₂ extraction and macroporous resin column chromatography to meet extreme global safety thresholds.
Dietary supplement and botanical IND filers require comprehensive Chemistry, Manufacturing, and Controls (CMC) dossiers. We furnish audited analytical protocols, stability profiles, and toxicological proof required to pass rigorous FDA, EFSA, and NMPA expert reviews.
Bridging the gap between raw ethnobotanical discovery and highly scalable, bioavailable finished product integration.
Overcome low intestinal permeability and rapid degradation. We engineer cyclodextrin micro-encapsulations, phytosome complexes, and spray-dried soluble matrices to maximize functional bio-absorption in dietary supplements.
Assisting biopharma in novel compound discovery. From target-directed fraction isolation to receptor affinity assays, phenotypic cellular screenings, and Phase I–IV clinical validation programs.
Meeting clean-beauty demands through non-irritating, decolorized, and odorless active plant molecules. Validated via in vitro epidermal permeation, elastase inhibition, and reactive oxygen species (ROS) quenching assays.
Digitizing and standardizing empirical medical formulas. We have successfully developed 56 registered hospital preparations, preserving synergistic therapeutic properties while enforcing modern chemical profiling.
Our laboratory infrastructure integrates multi-dimensional hyphenated chromatography and mass spectrometry to map complex botanical matrices.
Essential for precise quantitation of polyphenols, flavonoids, and non-volatile glycosides. We employ reverse-phase C18/C8 columns, gradient elution matrices, and diode-array detection alongside Evaporative Light Scattering Detection (ELSD) for substances lacking UV chromophores like saponins and triterpenoids.
Our primary method for botanical identification and adulteration screening. Utilizing automated sample application and computerized image analysis under specific UV spectrum bands (254nm, 366nm) to generate unambiguous planar chromatographic fingerprints comparing target specimens with certified reference standards.
Configured for volatile terpenes, essential oils, residual extraction solvents, and trace pesticide residues. Triple-quadrupole tandem mass spectrometry facilitates sub-ppb detection limits, verifying compliance with the most stringent regional pharmacopeial requirements.
Reliable international contracts backed by cGMP, ISO, Non-Disclosure Safeguards, and direct regulatory filing documentation.
Our entrusted contract R&D model operates under strict confidentiality protocols. Formulations, proprietary extraction steps, and chemical spectra remain client IP. Production workflows run within isolated cleanrooms to avoid cross-contamination and intellectual leaks.
Shipments are accompanied by comprehensive batch documentation: Certificates of Analysis (COA), safety data sheets (SDS), pesticide/heavy metal panels, non-irradiation declarations, allergen certificates, and stability test logs supporting customer regulatory submissions.
Direct access to project lead scientists and analytical chemists. We eliminate the communication gap between commercial buyers and factory floor technicians, facilitating real-time adjustment of specifications, particle sizes, or bulk densities.
Key technical, regulatory, and logistical inquiries addressed for procurement leaders and drug development directors.
Select an specialized service division to initiate your custom formulation, analytical assay, or contract manufacturing program.
